Global Nitric Oxide Therapy Device Market Growth 2025-2031

The global Nitric Oxide Therapy Device market size is predicted to grow from US$ 40.6 million in 2025 to US$ 57.6 million in 2031; it is expected to grow at a CAGR of 6.0% from 2025 to 2031.

Nitric oxide therapy device, also called nitric oxide inhalation therapy device, is a medical device that inhales nitric oxide (NO) to patients to treat diseases.

Clinically, nitric oxide therapy devices are generally used in conjunction with ventilators to treat pulmonary hypertension, respiratory failure, acute respiratory distress syndrome (ARDS), chronic obstructive pulmonary disease (COPD), high altitude pulmonary edema (HAPE), Acute pneumonia, acute pulmonary embolism, bronchial asthma, inhalation lung injury and other diseases, the applicable group includes newborns, children, and adults. It can improve the arterial pressure, ventilation capacity, and oxygenation capacity of the patient"s lungs.

LP Information, Inc. (LPI) ' newest research report, the “Nitric Oxide Therapy Device Industry Forecast” looks at past sales and reviews total world Nitric Oxide Therapy Device sales in 2024, providing a comprehensive analysis by region and market sector of projected Nitric Oxide Therapy Device sales for 2025 through 2031. With Nitric Oxide Therapy Device sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Nitric Oxide Therapy Device industry.

This Insight Report provides a comprehensive analysis of the global Nitric Oxide Therapy Device landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Nitric Oxide Therapy Device portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Nitric Oxide Therapy Device market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Nitric Oxide Therapy Device and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Nitric Oxide Therapy Device.

This report presents a comprehensive overview, market shares, and growth opportunities of Nitric Oxide Therapy Device market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
Fixed
Portable

Segmentation by Application:
Hospital
Rehabilitation Center
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Mallinckrodt
Praxair
Air Liquide
Beyond Air
Bellerophon Therapeutics
VERO Biotech
Third Pole

Key Questions Addressed in this Report

What is the 10-year outlook for the global Nitric Oxide Therapy Device market?

What factors are driving Nitric Oxide Therapy Device market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Nitric Oxide Therapy Device market opportunities vary by end market size?

How does Nitric Oxide Therapy Device break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver.